Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 227Carcinoma, Non-Small-Cell Lung 220Prostatic Neoplasms 156Multiple Myeloma 142Neoplasms 134Colorectal Neoplasms 118Leukemia, Myeloid, Acute 109Lung Neoplasms 103Neoplasm Metastasis 99Squamous Cell Carcinoma of Head and Neck 93Carcinoma, Hepatocellular 85Lymphoma 80Melanoma 77Pancreatic Neoplasms 73Triple Negative Breast Neoplasms 72Ovarian Neoplasms 71Sarcoma 66Lymphoma, Large B-Cell, Diffuse 62Recurrence 61Head and Neck Neoplasms 60Carcinoma, Renal Cell 59Brain Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Lymphoma, Non-Hodgkin 54Endometrial Neoplasms 54Leukemia, Lymphocytic, Chronic, B-Cell 53Hematologic Neoplasms 53Stomach Neoplasms 52Small Cell Lung Carcinoma 50Urinary Bladder Neoplasms 47

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Thiotepa 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Choriocarcinoma × 90 days × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡